Table 1.
Immunological evaluation of a patient with Down syndrome disintegrative disorder.
| Result and reference range | |
|---|---|
| Immunologic measures | |
| Autoimmune encephalopathy panel (serum) | See Supplementary Table 1 |
| Anti-cardiolipin antibody | Anti-cardiolipin IgG = 1 (≤ 15 units); IgM = 5 (≤ 14 units); IgA = 1 (≤ 14 units) |
| Angiotensin-converting enzyme | 50 (22-108 U/L) |
| Anti-Beta-2-glycoprotein 1 | IgG = 1 (≤ 20 units); IgM = 2 (≤ 20 units); IgA = 1 (≤ 20 units) |
| Von willebrand factor | 89.0 (40.0–190.0%) |
| Lupus anticoagulant panel | See Supplementary Table 2 |
| Anti-thyroglobulin antibodies | <1.8 (<4.0 IU/mL) |
| Anti-microsomal (thyroperoxidase) antibodies | 0.9 (<9.0 IU/mL) |
| Anti-nuclear antibody screen | Positive (1:40 Speckled) |
| Anti-streptolysin O | 469 (≤ 99 IU/mL) |
| Basic laboratory measures | |
| Complete blood count | See Supplementary Table 3 |
| Sedimentation rate | 2 (0–13 mm/h) |
| C-reactive protein | <0.02 (≤ 0.60 mg/dL) |
| Comprehensive metabolic panel | See Supplementary Table 4 |
| Thyroid stimulating hormone | 2.229 (0.200–4.500 IUI/mL) |
| Cerebrospinal fluid analyses | |
| Cell counts | See Supplementary Table 5 |
| Glucose | 61 (60–80 mg/dL) |
| Protein | 34 (15–45 mg/dL) |